Seoul, South Korea

Dae Hwan Suk

This inventor holds 2 USPTO granted patents. Top assignee: Korea Institute of Science and Technology. Active years: 1997-1999.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1997-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Dae Hwan Suk: Innovator in Antibacterial Agents

Introduction

Dae Hwan Suk is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of antibacterial agents, particularly through his innovative cephalosporin compounds. With a total of 2 patents, his work is recognized for its potential impact on healthcare.

Latest Patents

Dae Hwan Suk's latest patents include the development of 3-ammoniopropenyl cephalosporin compounds as antibacterial agents. These compounds exhibit good antibacterial activities against a wide variety of Gram-positive and Gram-negative bacteria. His patents detail a specific formula for these compounds, which includes hydroxylated alicyclic or aliphatic amines, showcasing their effectiveness in combating bacterial infections.

Career Highlights

Dae Hwan Suk is affiliated with the Korea Institute of Science and Technology, where he conducts his research and development. His work focuses on creating innovative solutions to address pressing health challenges, particularly in the realm of antibiotic resistance.

Collaborations

Some of his notable coworkers include Yong Sup Lee and Hokoon Park, who contribute to the collaborative efforts in research and development at the Korea Institute of Science and Technology.

Conclusion

Dae Hwan Suk's contributions to the field of antibacterial agents highlight his role as an influential inventor. His innovative work continues to pave the way for advancements in medical science and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…